Literature DB >> 19895152

Quantitative optical spectroscopy can identify long-term local tumor control in irradiated murine head and neck xenografts.

Karthik Vishwanath1, Daniel Klein, Kevin Chang, Thies Schroeder, Mark W Dewhirst, Nimmi Ramanujam.   

Abstract

Noninvasive and longitudinal monitoring of tumor oxygenation status using quantitative diffuse reflectance spectroscopy is used to test whether a final treatment outcome could be estimated from early optical signatures in a murine model of head and neck cancer when treated with radiation. Implanted tumors in the flank of 23 nude mice are exposed to 39 Gy of radiation, while 11 animals exposed to sham irradiation serve as controls. Diffuse optical reflectance is measured from the tumors at baseline (prior to irradiation) and then serially until 17 days posttreatment. The fastest and greatest increase in baseline-corrected blood oxygen saturation levels are observed from the animals that show complete tumor regression with no recurrence 90 days postirradiation, relative to both untreated and treated animals with local recurrences. These increases in saturation are observed starting 5 days posttreatment and last up to 17 days posttreatment. This preclinical study demonstrates that diffuse reflectance spectroscopy could provide a practical method far more effective than the growth delay assay to prognosticate treatment outcome in solid tumors and may hold significant translational promise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895152      PMCID: PMC2776819          DOI: 10.1117/1.3251013

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  12 in total

1.  Monte Carlo-based inverse model for calculating tissue optical properties. Part I: Theory and validation on synthetic phantoms.

Authors:  Gregory M Palmer; Nirmala Ramanujam
Journal:  Appl Opt       Date:  2006-02-10       Impact factor: 1.980

2.  Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

Authors:  Marianne Nordsmark; Søren M Bentzen; Volker Rudat; David Brizel; Eric Lartigau; Peter Stadler; Axel Becker; Markus Adam; Michael Molls; Juergen Dunst; David J Terris; Jens Overgaard
Journal:  Radiother Oncol       Date:  2005-08-10       Impact factor: 6.280

3.  Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development.

Authors:  Brian S Sorg; Benjamin J Moeller; Owen Donovan; Yiting Cao; Mark W Dewhirst
Journal:  J Biomed Opt       Date:  2005 Jul-Aug       Impact factor: 3.170

Review 4.  Assessing responses to cancer therapy using molecular imaging.

Authors:  André A Neves; Kevin M Brindle
Journal:  Biochim Biophys Acta       Date:  2006-10-24

5.  Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.

Authors:  G M Tozer; V E Prise; J Wilson; M Cemazar; S Shan; M W Dewhirst; P R Barber; B Vojnovic; D J Chaplin
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

6.  Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation.

Authors:  C Petersen; D Zips; M Krause; K Schöne; W Eicheler; C Hoinkis; H D Thames; M Baumann
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

7.  Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome.

Authors:  D M Brizel; R K Dodge; R W Clough; M W Dewhirst
Journal:  Radiother Oncol       Date:  1999-11       Impact factor: 6.280

Review 8.  Impact of hemoglobin levels on tumor oxygenation: the higher, the better?

Authors:  Peter Vaupel; Arnulf Mayer; Michael Höckel
Journal:  Strahlenther Onkol       Date:  2006-02       Impact factor: 3.621

9.  Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.

Authors:  Hsing-Wen Wang; Mary E Putt; Michael J Emanuele; Daniel B Shin; Eli Glatstein; Arjun G Yodh; Theresa M Busch
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

Review 10.  Combretastatin A4 phosphate: background and current clinical status.

Authors:  Scott L Young; David J Chaplin
Journal:  Expert Opin Investig Drugs       Date:  2004-09       Impact factor: 6.206

View more
  23 in total

1.  Portable, Fiber-Based, Diffuse Reflection Spectroscopy (DRS) Systems for Estimating Tissue Optical Properties.

Authors:  Karthik Vishwanath; Kevin Chang; Daniel Klein; Yu Feng Deng; Vivide Chang; Janelle E Phelps; Nimmi Ramanujam
Journal:  Appl Spectrosc       Date:  2011-02-01       Impact factor: 2.388

2.  Experimental validation of an inverse fluorescence Monte Carlo model to extract concentrations of metabolically relevant fluorophores from turbid phantoms and a murine tumor model.

Authors:  Chengbo Liu; Narasimhan Rajaram; Karthik Vishwanath; Tony Jiang; Gregory M Palmer; Nirmala Ramanujam
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

3.  Optical properties of breast tumor phantoms containing carbon nanotubes and nanohorns.

Authors:  Saugata Sarkar; Abhijit A Gurjarpadhye; Christopher G Rylander; Marissa Nichole Rylander
Journal:  J Biomed Opt       Date:  2011-05       Impact factor: 3.170

Review 4.  Application of optical imaging and spectroscopy to radiation biology.

Authors:  Gregory M Palmer; Karthik Vishwanath; Mark W Dewhirst
Journal:  Radiat Res       Date:  2012-02-23       Impact factor: 2.841

5.  Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics.

Authors:  Parisa Farzam; Johannes Johansson; Miguel Mireles; Gabriela Jiménez-Valerio; Mar Martínez-Lozano; Regine Choe; Oriol Casanovas; Turgut Durduran
Journal:  Biomed Opt Express       Date:  2017-04-19       Impact factor: 3.732

6.  Assessing effects of pressure on tumor and normal tissue physiology using an automated self-calibrated, pressure-sensing probe for diffuse reflectance spectroscopy.

Authors:  Gregory M Palmer; Hengtao Zhang; Chen-Ting Lee; Husam Mikati; Joseph A Herbert; Marlee Krieger; Jesko von Windheim; Dave Koester; Daniel Stevenson; Daniel J Rocke; Ramon Esclamado; Alaatin Erkanli; Nirmala Ramanujam; Mark W Dewhirst; Walter T Lee
Journal:  J Biomed Opt       Date:  2018-05       Impact factor: 3.170

Review 7.  Molecular imaging of hypoxia.

Authors:  Satish K Chitneni; Gregory M Palmer; Michael R Zalutsky; Mark W Dewhirst
Journal:  J Nucl Med       Date:  2011-01-13       Impact factor: 10.057

8.  18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.

Authors:  Satish K Chitneni; Gerald T Bida; Hong Yuan; Gregory M Palmer; Michael P Hay; Thorsten Melcher; William R Wilson; Michael R Zalutsky; Mark W Dewhirst
Journal:  J Nucl Med       Date:  2013-06-05       Impact factor: 10.057

Review 9.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

10.  Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy.

Authors:  Gabriel Ramirez; Ashley R Proctor; Ki Won Jung; Tong Tong Wu; Songfeng Han; Russell R Adams; Jingxuan Ren; Daniel K Byun; Kelley S Madden; Edward B Brown; Thomas H Foster; Parisa Farzam; Turgut Durduran; Regine Choe
Journal:  Biomed Opt Express       Date:  2016-08-24       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.